Cipher Pharmaceuticals Inc. announced the appointment of senior finance executive Bryan Jacobs as Chief Financial Officer ("CFO") effective August 15, 2022. Mr. Jacobs has over 18 years' experience in financial and operational management, cost and risk management at companies across pharmaceuticals, manufacturing and technology companies in Canada. He is an accomplished strategic financial leader and has extensive experience in public company compliance, financings as well as mergers and acquisitions.

Mr. Jacobs holds a Bachelor's degree in commerce is a chartered professional accountant (CPA) and chartered accountant (CA). Current CFO Scott Langille will remain with Cipher, focusing on business development and strategic mergers and acquisitions.